Literature DB >> 16569848

Novel carbapenem-hydrolyzing oxacillinase OXA-62 from Pandoraea pnomenusa.

Ines Schneider1, Anne Marie Queenan, Adolf Bauernfeind.   

Abstract

Pandoraea spp. are gram-negative, glucose nonfermenting rods detectable in blood cultures and sputa of cystic fibrosis patients. They are resistant to various antibiotic groups, with imipenem being the only active beta-lactam. We isolated an imipenem-resistant (MIC, 64 microg/ml) Pandoraea pnomenusa strain from a cystic fibrosis patient. Cloning and sequencing identified two beta-lactamases of Bush group 2d, namely, the known OXA-33, located on an integron, and the novel carbapenem-hydrolyzing oxacillinase OXA-62. OXA-62 is only distantly related to other oxacillinases (OXA-50 being closest with 43% amino acid identity). It hydrolyzes penicillins, oxacillin, imipenem, and meropenem but not expanded-spectrum cephalosporins. The blaOXA-62 gene is chromosome located. No transposable elements were found in its genetic neighborhood. With OXA-62-specific primers, blaOXA-62 could be identified in all P. pnomenusa strains and appears to be species specific. This additional mechanism of carbapenem resistance further complicates the treatment of infections caused by P. pnomenusa.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16569848      PMCID: PMC1426949          DOI: 10.1128/AAC.50.4.1330-1335.2006

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Characterization of In111, a class 1 integron that carries the extended-spectrum beta-lactamase gene blaIBC-1.

Authors:  S Vourli; L S Tzouvelekis; E Tzelepi; E Lebessi; N J Legakis; V Miriagou
Journal:  FEMS Microbiol Lett       Date:  2003-08-08       Impact factor: 2.742

2.  Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii.

Authors:  M Afzal-Shah; N Woodford; D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

3.  In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor.

Authors:  K Coleman; D R Griffin; J W Page; P A Upshon
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

4.  OXA-60, a chromosomal, inducible, and imipenem-hydrolyzing class D beta-lactamase from Ralstonia pickettii.

Authors:  Delphine Girlich; Thierry Naas; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

5.  Complete genome structure of the nitrogen-fixing symbiotic bacterium Mesorhizobium loti.

Authors:  T Kaneko; Y Nakamura; S Sato; E Asamizu; T Kato; S Sasamoto; A Watanabe; K Idesawa; A Ishikawa; K Kawashima; T Kimura; Y Kishida; C Kiyokawa; M Kohara; M Matsumoto; A Matsuno; Y Mochizuki; S Nakayama; N Nakazaki; S Shimpo; M Sugimoto; C Takeuchi; M Yamada; S Tabata
Journal:  DNA Res       Date:  2000-12-31       Impact factor: 4.458

6.  OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain.

Authors:  G Bou; A Oliver; J Martínez-Beltrán
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

7.  Sepsis, multiple organ failure, and death due to Pandoraea pnomenusa infection after lung transplantation.

Authors:  Martin E Stryjewski; John J LiPuma; Robert H Messier; L Barth Reller; Barbara D Alexander
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

8.  Genetic and functional analysis of the chromosome-encoded carbapenem-hydrolyzing oxacillinase OXA-40 of Acinetobacter baumannii.

Authors:  Claire Héritier; Laurent Poirel; Daniel Aubert; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

9.  ARI 1: beta-lactamase-mediated imipenem resistance in Acinetobacter baumannii.

Authors:  R Paton; R S Miles; J Hood; S G Amyes; R S Miles; S G Amyes
Journal:  Int J Antimicrob Agents       Date:  1993-02       Impact factor: 5.283

10.  Pandoraea bacteremia in a cystic fibrosis patient with associated systemic illness.

Authors:  Lindsey N Johnson; Jin-Young Han; Samuel M Moskowitz; Jane L Burns; Xuan Qin; Janet A Englund
Journal:  Pediatr Infect Dis J       Date:  2004-09       Impact factor: 2.129

View more
  19 in total

1.  Intrinsic carbapenem-hydrolyzing oxacillinases from members of the genus Pandoraea.

Authors:  Ines Schneider; Adolf Bauernfeind
Journal:  Antimicrob Agents Chemother       Date:  2015-09-08       Impact factor: 5.191

2.  Characterization of the First OXA-10 Natural Variant with Increased Carbapenemase Activity.

Authors:  Stathis D Kotsakis; Carl-Fredrik Flach; Mohammad Razavi; D G Joakim Larsson
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

Review 3.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

Review 4.  Updated functional classification of beta-lactamases.

Authors:  Karen Bush; George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2009-12-07       Impact factor: 5.191

5.  Characterization of a Carbapenem-Hydrolyzing Enzyme, PoxB, in Pseudomonas aeruginosa PAO1.

Authors:  Diansy Zincke; Deepak Balasubramanian; Lynn L Silver; Kalai Mathee
Journal:  Antimicrob Agents Chemother       Date:  2015-11-30       Impact factor: 5.191

Review 6.  Diversity, epidemiology, and genetics of class D beta-lactamases.

Authors:  Laurent Poirel; Thierry Naas; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-08-31       Impact factor: 5.191

7.  Complete Genome Sequence Analysis of Pandoraea pnomenusa Type Strain DSM 16536(T) Isolated from a Cystic Fibrosis Patient.

Authors:  Yan-Lue Lim; Robson Ee; Delicia Yong; Choo-Yee Yu; Geik-Yong Ang; Kok-Keng Tee; Wai-Fong Yin; Kok-Gan Chan
Journal:  Front Microbiol       Date:  2016-02-08       Impact factor: 5.640

8.  First time identification of Pandoraea sputorum from a patient with cystic fibrosis in Argentina: a case report.

Authors:  Pablo F Martina; Mónica Martínez; Guillermo Frada; Florencia Alvarez; Lorena Leguizamón; Claudia Prieto; Carolina Barrias; Marisa Bettiol; Antonio Lagares; Alejandra Bosch; Julián Ferreras; Martha Von Specht
Journal:  BMC Pulm Med       Date:  2017-02-07       Impact factor: 3.317

9.  Complete genome sequencing of Pandoraea pnomenusa RB38 and Molecular Characterization of Its N-acyl homoserine lactone synthase gene ppnI.

Authors:  Yan-Lue Lim; Robson Ee; Kah-Yan How; Siew-Kim Lee; Delicia Yong; Kok Keng Tee; Wai-Fong Yin; Kok-Gan Chan
Journal:  PeerJ       Date:  2015-08-27       Impact factor: 2.984

Review 10.  Acquired Class D β-Lactamases.

Authors:  Nuno T Antunes; Jed F Fisher
Journal:  Antibiotics (Basel)       Date:  2014-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.